Literature DB >> 1415891

Functional postoperative treatment of Achilles tendon repair.

T R Carter1, P J Fowler, C Blokker.   

Abstract

Twenty-one patients with surgically repaired Achilles tendon tears that were treated postoperatively with a functional orthosis rather than routine cast immobilization were evaluated. The orthosis allowed unrestricted plantar flexion and limited dorsiflexion to neutral. Toe-touch weightbearing crutch ambulation was allowed immediately and was gradually increased over the 6 to 8 weeks of treatment. Of the 21 patients, 14 were men and 7 were women; the average age at injury was 35.6 years (range, 19 to 65). The minimum followup was 2 years, with an average of 31 months. The repairs were acute in 18 of the patients and chronic in 3. Subjectively, 16 patients felt they returned to their preinjury level of activity and only 1 was not satisfied with his result. Objectively, there were no significant alterations in ankle range of motion when compared to the contralateral limb, with plantar flexion unchanged and dorsiflexion increased an average of only 2 degrees. The average plantar flexion and dorsiflexion strength, power, and endurance of the ankles as measured by isokinetic testing revealed no significant differences when comparing the operated leg to the nonoperated side: strength, 99% and 93%, respectively; power, 98% and 96%, respectively; and endurance, 93% and 91%, respectively. The angles at which the peak torques occurred were similarly not statistically different. Two patients had superficial wound infections, and 1 had scar adherence of the skin to the tendon. No one had rerupture of the tendon. In conclusion, while the many benefits of postoperative early motion are well proven, there has been hesitation to implement this after Achilles tendon surgery due to the concern of compromising the repair. As shown by this study, early controlled motion can safely and effectively be used following Achilles tendon repair in the motivated, reliable patient.

Entities:  

Mesh:

Year:  1992        PMID: 1415891     DOI: 10.1177/036354659202000417

Source DB:  PubMed          Journal:  Am J Sports Med        ISSN: 0363-5465            Impact factor:   6.202


  17 in total

1.  [Not Available].

Authors:  A Sutherland; N Maffulli
Journal:  Oper Orthop Traumatol       Date:  1998-03       Impact factor: 1.154

2.  Pectoralis major tendon repair post surgical rehabilitation.

Authors:  Robert C Manske; Dan Prohaska
Journal:  N Am J Sports Phys Ther       Date:  2007-02

Review 3.  Subcutaneous rupture of the Achilles tendon: basic science and some aspects of clinical practice.

Authors:  S W Waterston; N Maffulli; S W Ewen
Journal:  Br J Sports Med       Date:  1997-12       Impact factor: 13.800

4.  Achilles tendon rupture.

Authors:  N Maffulli
Journal:  Br J Sports Med       Date:  1995-12       Impact factor: 13.800

5.  CORR Insights®: Is Dual Semitendinosus Allograft Stronger Than Turndown for Achilles Tendon Reconstruction? An In Vitro Analysis.

Authors:  Nicola Maffulli
Journal:  Clin Orthop Relat Res       Date:  2017-07-21       Impact factor: 4.176

6.  Subcutaneous suturing of the ruptured Achilles tendon under local anaesthesia.

Authors:  M Kosanović; A Cretnik; M Batista
Journal:  Arch Orthop Trauma Surg       Date:  1994       Impact factor: 3.067

7.  The relative stress on the Achilles tendon during ambulation in an ankle immobiliser: implications for rehabilitation after Achilles tendon repair.

Authors:  K H Akizuki; E J Gartman; B Nisonson; S Ben-Avi; M P McHugh
Journal:  Br J Sports Med       Date:  2001-10       Impact factor: 13.800

Review 8.  Total Achilles tendon rupture. A review.

Authors:  J Leppilahti; S Orava
Journal:  Sports Med       Date:  1998-02       Impact factor: 11.136

Review 9.  Achilles tendon injuries in athletes.

Authors:  M Kvist
Journal:  Sports Med       Date:  1994-09       Impact factor: 11.136

10.  Progressive management of open surgical repair of achilles tendon rupture.

Authors:  D H Dugan; C K Hobler
Journal:  J Athl Train       Date:  1994-12       Impact factor: 2.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.